Literature DB >> 29052293

Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor.

X Long1,2, M Li1,2, L-X Li1,2, Y-Y Sun1,2, W-X Zhang1,2, D-Y Zhao3, Y-Q Li1,2.   

Abstract

BACKGROUND: Altered visceral sensation is common in irritable bowel syndrome (IBS) and nerve growth factor (NGF) participates in visceral pain development. Sodium butyrate (NaB) could induce colonic hypersensitivity via peripheral up-regulation of NGF in animals. Enteric glial cells (EGCs) appear to be an important source of NGF. Whether butyrate could induce visceral hypersensitivity via increased EGC-derived NGF is still unknown.
METHODS: CRL-2690 cells were used for transcriptome analyses after butyrate treatment. Rats received butyrate enemas to induce colonic hypersensitivity. Colorectal distention test was performed to assess visceral sensitivity. Immunofluorescence studies were used to evaluate the co-expression of glial fibrillary acidic protein (GFAP) and NGF or growth associated protein 43 in animal model. NGF expression in rat colon was also investigated. In vitro, CRL-2690 cells were stimulated with NaB or trichostatin A (TSA). NGF or GFAP expression was also examined. KEY
RESULTS: Transcriptome analyses showed that butyrate induced marked changes of genes expression related to neurotrophic signaling pathways. NaB-treated rats showed increased visceral sensitivity. An improved NGF expression level was observed in NaB-treated rats. Meanwhile, a 2.1-fold increase in co-expression of GFAP and NGF was also determined in rats received NaB enemas. In cultured cells, both NaB and TSA treatment could cause obvious NGF expression. Thus, butyrate might regulate EGC function via histone deacetylase inhibition. CONCLUSIONS & INFERENCES: Butyrate-EGC interplay may play a pivotal role in regulation of NGF expression and the development of colonic hypersensitivity in IBS-like animal model.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990EGCzzm321990; zzm321990IBSzzm321990; zzm321990NGFzzm321990; sodium butyrate; visceral hypersensitivity

Mesh:

Substances:

Year:  2017        PMID: 29052293     DOI: 10.1111/nmo.13227

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  15 in total

Review 1.  Enteric glial biology, intercellular signalling and roles in gastrointestinal disease.

Authors:  Luisa Seguella; Brian D Gulbransen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-17       Impact factor: 46.802

2.  Effect of Reactive EGCs on Intestinal Motility and Enteric Neurons During Endotoxemia.

Authors:  Na Li; Jing Xu; Hui Gao; Yuxin Zhang; Yansong Li; Haiqing Chang; Shuwen Tan; Shuang Li; Qiang Wang
Journal:  J Mol Neurosci       Date:  2022-06-30       Impact factor: 2.866

3.  Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.

Authors:  Vladimir T Ivashkin; Anna V Kudryavtseva; George S Krasnov; Yuri M Poluektov; Margarita A Morozova; Oleg S Shifrin; Allan G Beniashvili; Zarina A Mamieva; Alexandra L Kovaleva; Anatoly I Ulyanin; Elizaveta A Trush; Alexander G Erlykin; Elena A Poluektova
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

Review 4.  Neurotrophic factors in enteric physiology and pathophysiology.

Authors:  Sumei Liu
Journal:  Neurogastroenterol Motil       Date:  2018-10       Impact factor: 3.598

5.  Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41/43 receptors.

Authors:  Maksymilian Onyszkiewicz; Marta Gawrys-Kopczynska; Piotr Konopelski; Marta Aleksandrowicz; Aneta Sawicka; Ewa Koźniewska; Emilia Samborowska; Marcin Ufnal
Journal:  Pflugers Arch       Date:  2019-11-15       Impact factor: 3.657

Review 6.  Mechanisms of microbial-neuronal interactions in pain and nociception.

Authors:  Valentina N Lagomarsino; Aleksandar D Kostic; Isaac M Chiu
Journal:  Neurobiol Pain       Date:  2020-12-11

7.  Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

8.  Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.

Authors:  Tsukasa Nozu; Saori Miyagishi; Rintaro Nozu; Kaoru Takakusaki; Toshikatsu Okumura
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

Review 9.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

10.  Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice.

Authors:  Raiza R Bonomo; Tyler M Cook; Chaitanya K Gavini; Chelsea R White; Jacob R Jones; Elisa Bovo; Aleksey V Zima; Isabelle A Brown; Lara R Dugas; Eleonora Zakharian; Gregory Aubert; Francis Alonzo; Nigel A Calcutt; Virginie Mansuy-Aubert
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.